Dr. Ming Jiang 蒋鸣
Chief Physician
Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy and comprehensive treatment for thoracic tumors, including esophageal cancer and lung cancer.
Dr. Jiang is a Chief Physician with 26 years of clinical experience. Focus includes treatment of thoracic tumors such as lung cancer, esophageal cancer, breast cancer, and thymoma. Has published dozens of articles, including SCI-indexed papers.
Professional roles
- Member, Chinese Medical Association
- Member, Thermal Therapy Group of the Society of Radiation Oncology, Chinese Medical Association
- Member, Committee on Radiation Oncology, Jiangsu Anti-Cancer Association
- Member, Esophageal Cancer Professional Committee, Jiangsu Anti-Cancer Association
Name order: in Chinese the family name comes first (Jiang Ming). Papers usually list the name as Ming Jiang or Jiang M.
Selected publications
18 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Immunother Cancer, 2024 (senior author): Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial. PubMed 38199609
- Exp Ther Med, 2020 (senior author): miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD. PubMed 32256796
- Thorac Cancer, 2019 (first author): Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. PubMed 31055884
- J Cell Biochem, 2019 (first author): Long noncoding RNA MEG3 play an important role in osteosarcoma development through sponging microRNAs. PubMed 30324678
- Biomed Pharmacother, 2018 (first author): Down-regulation of miR-500 and miR-628 suppress non-small cell lung cancer proliferation, migration and invasion by targeting ING1. PubMed 30372865
- Biomed Pharmacother, 2018 (senior author): The long non-coding RNA-DANCR exerts oncogenic functions in non-small cell lung cancer via miR-758-3p. PubMed 29635134
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion